Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$124,979,919
-$11,609,877 QoQ
Shares Held
5,190,196
+6.7% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#87
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STOREBRAND ASSET MANAGEMENT AS holds $1,607,022,504 across 10 Drug Manufacturers - General names. PFE ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
471,742 | $565,821,554 | |
| 2 | ABBV |
AbbVie Inc.
|
1,078,470 | $271,386,190 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,685,911 | $216,639,563 | |
| 4 | PFE |
Pfizer Inc
This page
|
5,190,196 | $124,979,919 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
939,277 | $118,668,256 | |
| 6 | AMGN |
Amgen Inc
|
325,992 | $118,048,223 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,753,508 | $101,037,130 | |
| 8 | JNJ |
Johnson & Johnson
|
342,270 | $86,926,311 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $124,979,919 | 5,190,196 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $136,589,796 | 4,864,309 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $119,457,476 | 4,797,489 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $122,371,471 | 4,802,648 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $112,556,040 | 4,643,401 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $113,474,825 | 4,478,091 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $115,805,280 | 4,365,069 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $118,774,361 | 4,104,159 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $113,566,203 | 4,058,835 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $119,142,599 | 4,293,427 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $117,517,267 | 4,081,878 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $116,343,741 | 3,507,499 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $132,175,646 | 3,603,480 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $133,412,736 | 3,269,920 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $167,080,625 | 3,260,746 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $141,786,075 | 3,240,084 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $171,394,404 | 3,269,014 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $177,415,324 | 3,426,991 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $190,751,399 | 3,230,337 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $139,546,504 | 3,244,513 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $128,775,388 | 3,288,442 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $121,026,496 | 3,340,505 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $117,402,034 | 3,189,406 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $98,684,914 | 2,834,169 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $85,449,376 | 2,754,237 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $80,510,848 | 2,599,833 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||